2019 will see the launch of three new peer-reviewed journals published by RSNA, including one dedicated to AI in medical imaging. On Monday, Nov. 26, at RSNA 2018 in Chicago, the managing editor of the new titles filled in some details on what to expect and watch for.
As time goes on, artificial intelligence (AI) is becoming more widely accepted as a necessary component of clinical workflow in medical imaging. According to Tarik K. Alkasab, MD, PhD, a radiologist at Massachusetts General Hospital in Boston, AI has the potential to make radiology reporting much more consistent and ultimately help radiologists make smarter decisions.
During her speech Sunday, Nov. 25, at the opening session of RSNA 2018 in Chicago, RSNA President Vijay Rao, MD, noted that today's radiologists will be empowered by new technologies, not replaced by them.
Providing high-quality customer service is a key component of any business strategy. After all, if your customers aren’t happy, why would they ever use your services again or recommend you to a friend?
With RSNA 2018 rapidly approaching, Signify Research has published a new report on the trends expected to steal the show. And, yes, artificial intelligence (AI) seems like an obvious choice for No. 1, but the report suggests another top trend: efficiency.
In late November, some 50,000 representatives from the medical imaging industry will once again gather at McCormick Place in Chicago for RSNA 2018. Vendors will share their latest and greatest solutions, attendees will take part in fascinating sessions and the convention center will burst with enthusiasm, energy and excitement.
Canon Medical Systems USA announced a collaboration with Applied Radiology to support two international expert-led symposiums that will discuss innovation within high resolution imaging and imaging techniques for liver assessment at the 2018 Radiological Society of North America (RSNA) annual meeting.
Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for patients with low- and intermediate-risk prostate cancer, according to research presented Oct. 22 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.